Use of Medications to Reduce Cardiovascular Risk Among Individuals With Psychotic Disorders and Type 2 Diabetes
Schizophrenia Research - Netherlands
doi 10.1016/j.schres.2008.02.004
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2008
Authors
Publisher
Elsevier BV